EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2272 participants.
Also called NCT01069003
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,272 participants
- Sponsor
- Registry
-
NCT01069003
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01069003. Randomized; triple masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2016-01-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
- Acronym
- EDUCATE
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Placebo Arm
- Intervention (Drug)
- Thienopyridine Therapy
- Intervention (Device)
- Surveillance Arm
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct01069003- Content hash
46c66d7ccdbed1bbf34a6c87cfd965f5df37e8591bd2144c29b02a96fce49f8f